Skip to content
Visnia
CtrlK
EconomyAI buildoutMarket MapFundsWatchlist
Log in
Market cap
Revenue
Net income
Cash on hand
Gross margin
Net margin
EPS
P/E ratio
Search
Market mapFundsWatchlist
Visnia

JJazz Pharmaceuticals plc

EconomyAI buildoutMarket MapFundsWatchlist
Log in
J

Jazz Pharmaceuticals plc

$240.57Close · Sep 22, 2026
  • Overview
  • Financial statements
  • Metrics
  • Quarterly earnings
  • Similar companies
  • History
  • Insider Transactions
Loading financials
Income statement income statement flow. Revenue $1.21B. Net result $192.8M.

Income statement revenue $1.21B (+15.5% YoY).Operating income $248.2M.Pre-tax result $210.9M.Net result $192.8M.

  • Cost of product sales (excluding amortization of acquired developed technologies): $116.4M (+0.1% YoY)
  • Selling, general and administrative: $389.2M (+8.6% YoY)
  • Research and development: $207.5M (+9.3% YoY)
  • Intangible asset amortization: $170M (+4.9% YoY)
  • Acquired in-process research and development: $77M (-91.5% YoY)
  • Other expense: $37.3M (-24.3% YoY)
  • Income tax expense: $18.1M